Skip to main content
. 2022 Jan 12;8:815628. doi: 10.3389/fmed.2021.815628

Table 4.

Comparison of the surgical findings of 233 recurrence of ovarian endometrioma according to the presence of adenomyosis.

Subtype II (n = 112) Other types of adenomyosis (n = 55) No adenomyosis (n = 66) P- value
DIE rate (n, %) 94 (83.93) 25 (45.45) 27 (40.91) 0.014
Mean total no. Of die lesions 3.6 ± 1.8 2.3 ± 1.5 2.2 ± 1.3 <0.01
No. Of lesions n = 1 (n, %) 31 (27.68) 27 (49.10) 38 (57.58)
No. Of lesions n ≥ 2 81 (72.32) 28 (50.91) 28 (42.42) <0.01
Usl 87 (77.68) 32 (58.18) 14 (21.21) <0.01
Bilateral 63 (72.41) 12 (37.5) 6 (42,86)
Unliteral 24 (27.59) 20 (62.5) 8 (57.14)
Right 11 9 4
Left 13 10 4
Ureter 45 (40.18) 14 (25.45) 6 (9.10) 0.03
Bilateral 32 (71.11) 8 (57.14) 3 (50.00)
Unliteral 13 (28.89) 6 (42.86) 3 (50.00)
Right 6 3 2
Left 7 3 1
Vagina 32 (28.57) 12 (21.82) 0 <0.01
Bladder 4 (3.57) 0 0 <0.01
Intestine 13 (11.61) 5 (9.10) 2 (3.03) <0.01
Punch of Douglas
Partial 21 (18.75) 25 (45.45) 36 (54.55) <0.01
Total 91 (81.25) 30 (54.55) 30 (45.45) <0.01
Mean total rasrm score 103.14 ± 23.89 74.23 ± 16.72 36.51 ± 14.23 <0.01
Mean implant rasrm score 32.66 ± 12.37 26.57 ± 13.45 24.45 ± 12.34 0.023
Mean adhesion rasrm score 36.71 ± 14.57 17.65 ± 10.42 15.63 ± 10.26 0.017
Stage III/IV 83 (74.10) 28 (50.91) 26 (39.40) <0.01

Data are presented as means ± the standard deviation and n (%) as appropriate. Kruskal–Wallis followed by post-hoc Dunn's test or ANOVA test; χ2-test or Fisher's exact test; p < 0.05.